Blade, Joby stocks rally after companies strike $125 million deal on helicopter ridesharing business

Blade Air Mobility (BLDE) is selling its helicopter passenger rideshare business to Joby Aviation (JOBY) for $125 million, prompting respective stock surges of 30% and 5%. This strategic acquisition provides Joby, which is pursuing FAA certification for its eVTOLs and aims for commercial flights next year, with an established air mobility operation. Concurrently, Blade will spin out its medical transport business into a new public entity, Strata Critical Medical, effectively streamlining its focus and providing capital following its unprofitable post-SPAC performance.

Analysis

Joby Aviation's (JOBY) $125 million acquisition of Blade Air Mobility's (BLDE) helicopter rideshare business is a significant strategic move that vertically integrates a future eVTOL manufacturer with an existing passenger network. For Joby, a $14.4 billion company backed by Toyota and pursuing FAA certification for its electric air taxis, this deal provides immediate access to Blade's established operational footprint, which includes 12 terminals and a history of flying over 50,000 passengers in 2024. This acquisition accelerates Joby's go-to-market strategy by providing a ready-made customer base and infrastructure ahead of its planned commercial launch next year. For Blade, the transaction represents a substantial monetization event, with the deal value equating to over 40% of its pre-announcement market cap of approximately $300 million. This provides critical capital for a company that has been unprofitable since its 2021 SPAC debut and has seen its stock decline roughly 60% since going public. The concurrent spin-off of its medical transport business into a new public entity, Strata Critical Medical, allows Blade to streamline its operations and unlock value while its passenger business continues under Joby's ownership.

Key Decisions for Investors

• For Joby Aviation (JOBY) investors, this acquisition de-risks the commercialization phase by securing an operational network, but the primary catalyst and risk factor remains the timely FAA certification of its eVTOL aircraft.
• Blade Air Mobility (BLDE) shareholders should view this as a successful monetization that provides substantial capital; future valuation will depend on the market's assessment of the new, focused medical transport spin-off, Strata Critical Medical.
• This transaction signals strategic consolidation in the Urban Air Mobility sector, and investors should monitor the successful integration of Blade's operations and Joby's progress toward its 2026 certification goals.